Understanding patient-reported outcomes in functional movement disorder: Association with clinical measures and change following integrative treatment

Understanding Patient-Reported Outcomes

Patient-reported outcomes (PROs) represent a crucial aspect of healthcare, capturing patients’ perceptions about their health status, quality of life, and treatment experiences. These outcomes prioritize the patient’s voice and provide insights that clinical measures alone may miss. In the context of functional movement disorders (FMD), understanding PROs is particularly significant as these conditions often present with subjective symptoms that can vary widely among individuals. By incorporating PROs into clinical practice, healthcare providers gain a more comprehensive view of how these disorders affect patients’ daily lives and their overall well-being.

PROs encompass various dimensions, including physical functioning, emotional well-being, and social role performance. For patients with FMD, common tools used to assess PROs include standardized questionnaires that focus on aspects such as symptom severity, physical limitations, and psychological distress. For instance, instruments like the Beck Depression Inventory (BDI) and the Short Form Health Survey (SF-36) are frequently utilized to quantify levels of depression and general health perception, respectively.

The relationship between PROs and clinical measures—such as motor performance assessments and neurological examinations—provides valuable information on the effectiveness of treatment interventions. While clinical measures offer objective data, they may not fully capture patient experiences or the impact of symptoms on daily life. Therefore, integrating PROs with traditional clinical assessments helps in tailoring treatment plans that align with patients’ personal health goals.

A recent study investigated the correlation between PROs and clinical measures among patients diagnosed with FMD. The findings revealed noteworthy associations, suggesting that as patients reported improvements in their symptoms and quality of life through PROs, there were corresponding positive changes in clinical measures. This indicates that effective treatment not only alleviates symptoms but also enhances patients’ overall perception of their health.

Ultimately, focusing on PROs facilitates a more patient-centered approach, aligning clinical outcomes with patients’ lived experiences. This perspective not only informs treatment efficacy but also fosters a therapeutic alliance between patients and healthcare providers, promoting better engagement and adherence to treatment plans.

Study Design and Participant Selection

The study employed a cross-sectional design to evaluate the relationship between patient-reported outcomes (PROs) and clinical measures in individuals diagnosed with functional movement disorders (FMD). Participants were recruited from a specialized movement disorder clinic, ensuring a population with a clear diagnosis of FMD as per the latest clinical guidelines. Inclusion criteria mandated that participants were above 18 years of age and could comprehend and complete the questionnaires relevant to the study.

To ensure the fidelity of the sample, individuals with comorbid neurological conditions, significant psychiatric disorders, or prior interventions targeting FMD were excluded from participation. These exclusions aimed to minimize confounding factors that could skew the results concerning the efficacy of the integrative treatment being assessed. The final sample comprised 100 participants, a size considered adequate to provide reliable data while allowing for the analysis of potential subgroups based on symptom severity and demographic characteristics.

After initial screening, participants provided informed consent to partake in the study. They completed various PRO measures, including the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), which assesses motor and non-motor symptoms, and the Functional Impact Scale (FIS), which captures how movement disorders disrupt daily activities and overall quality of life.

Data collection occurred over several visits, ensuring that researchers could correlate PROs with clinical assessments performed concurrently by trained neurologists. Each participant underwent a thorough neurological examination, and motor performance was quantified through standardized tests, such as the Timed Up and Go (TUG) test and the Berg Balance Scale (BBS). These measures enabled a comprehensive profile of each participant’s condition.

The demographic characteristics of the study population are summarized in Table 1, highlighting age, gender distribution, and FMD subtype. This characterization is essential for understanding the diversity within the sample and assessing the generalizability of the findings.

This structured approach to study design and participant selection enabled in-depth analysis of the interrelations between PROs and clinical measures, forming a robust basis for the subsequent evaluation of treatment efficacy. The careful delineation of participant characteristics not only aids in interpreting the data but also enhances the contextual understanding necessary for appropriate clinical applications.

Results and Analysis of Clinical Measures

The analysis focused on the interplay between patient-reported outcomes (PROs) and established clinical measures, revealing significant insights into how functional movement disorders (FMD) manifest in clinical settings. The study’s results indicate a notable correlation between PRO scores and various clinical assessments, underscoring the importance of integrating subjective measures with objective evaluations in managing FMD.

As part of the assessment, participants completed the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) alongside newer measures, such as the Functional Impact Scale (FIS). The MDS-UPDRS was tailored to evaluate both motor and non-motor symptoms, providing a comprehensive framework for interpreting patients’ experiences. The FIS, on the other hand, specifically captured how movement disorders interfered with daily life and overall quality of life. Participants reported their symptoms levels on these scales, which were then quantitatively analyzed against motor performance tests such as the Timed Up and Go (TUG) test and the Berg Balance Scale (BBS).

Significant findings emerged when examining the correlation coefficients between PROs and clinical measures. For instance, higher scores on the FIS were strongly associated with increased times recorded on the TUG test, indicating that participants who perceived greater functional impact reflected worse motor performance objectively. This relationship is illustrated in Table 2, which presents the correlation coefficients between the PROs and clinical measures.

The analysis indicates a positive correlation between MDS-UPDRS total scores and FIS, suggesting that as self-reported functional impact increased, so too did the severity of motor and non-motor symptoms assessed by neurological evaluation. Conversely, the BBS presented a negative correlation with the FIS, which aligns with expectations that poorer balance would correlate with greater perceived limitations in daily activities.

Further stratification of results based on FMD subtypes revealed distinctive patterns. For those diagnosed with psychogenic FMD, the PROs indicated a higher emotional distress level compared to individuals with dystonic or tremor subtypes. This finding prompts a deeper consideration of individual characteristics, highlighting that subjective experiences can vary significantly within the same diagnosis, raising the importance of personalized care in treatment approaches.

Moreover, the study utilized regression analysis to determine predictors of changes in clinical measures following integrative treatment. PROs emerged as consistent predictors of clinical improvement, emphasizing their role in guiding therapeutic interventions. This relationship showcases the value of incorporating patient feedback into treatment planning, as improved PRO scores were linked with better clinical outcomes across all assessed motor measures.

Responses illustrated through patients’ narratives further corroborated the quantitative data, showcasing how improvements in perceived well-being directly influenced their motivation to engage in rehabilitation practices. This qualitative feedback can provide context to statistical outcomes, reinforcing the necessity of a holistic perspective in managing functional movement disorders.

The detailed evaluation of clinical measures alongside PROs demonstrates that understanding both quantitative and qualitative aspects of patient experience can lead to more targeted and effective treatment strategies. By embracing this dual approach, healthcare providers can better align clinical objectives with patient-centered care, facilitating enhanced recovery trajectories in FMD patients.

Evaluation of Treatment Efficacy

The integrative treatment regimen was systematically evaluated to ascertain its effect on both patient-reported outcomes (PROs) and clinical measures in individuals diagnosed with functional movement disorders (FMD). This approach underscored the importance of assessing treatment efficacy from both the patient’s and clinician’s perspectives, thus promoting a holistic view of recovery.

Participants underwent several sessions of integrative treatment, which combined various therapeutic modalities, including physical therapy, cognitive behavioral therapy, and mindfulness techniques. The treatment aimed not only to improve motor functions but also to address underlying psychological issues that often accompany FMD, such as anxiety and depression. Data was collected pre-treatment and post-treatment at defined intervals to monitor changes in PROs and clinical measures.

Upon completion of the treatment program, a significant improvement was observed in the participants’ PRO scores across various metrics, particularly those related to pain, mobility, and psychological well-being. For instance, the Functional Impact Scale (FIS) scores decreased, suggesting a reduced perception of how the disorder limited daily activities post-treatment. In parallel, clinical assessments revealed improvements in motor function as indicated by the Timed Up and Go (TUG) test and the Berg Balance Scale (BBS), further validating the treatment’s efficacy.

Table 3 summarizes the change in mean scores of PROs and clinical measures before and after treatment:

The data demonstrates a marked reduction in the perceived functional impact of the disorder, alongside improved physical measures, suggesting that integrative treatment positively influenced both subjective and objective parameters of health. To further quantify the treatment’s impact, regression analyses revealed that improvements in PRO scores were predictive of positive changes in clinical measures. This finding emphasizes the significance of focusing on patient experiences when evaluating treatment outcomes, as subjective improvements can foreshadow objective recovery trajectories.

A qualitative aspect of the study was underscored by participant feedback, which highlighted an increased sense of autonomy and control over their conditions post-treatment. Many expressed feelings of relief and hope, articulating how the integrative techniques helped them address both the physical limitations imposed by FMD and the psychological factors that often exacerbated their symptoms. Such insights not only provide additional context to the quantitative data but also reaffirm the necessity of incorporating a patient-centered approach in treatment design.

The evaluation of treatment efficacy revealed that a multifaceted approach, which includes both psychological and physical rehabilitation strategies, can lead to significant improvements in patient-reported outcomes and clinical measures in individuals with functional movement disorders. This evidence advocates for ongoing integration of PROs into clinical trials and routine practice, ensuring that the treatment landscape is responsive to the nuanced needs of patients facing these complex conditions.